Takeda and existing investor Allianz X took part in a series C round closed in the wake of heightened demand for Amwell's telehealth technology platform.
US-based telehealth technology provider Amwell completed a $194m series C round yesterday that was backed by pharmaceutical firm Takeda and Allianz X, insurance group Allianz’s digital investment arm.
Formerly known as American Well, Amwell has built a telehealth system used by some 2,000 hospitals, allowing care providers to remotely speak to and assess patients. It said use of the platform has increased significantly over recent weeks as patients seek diagnoses of possible Covid-19 symptoms.
The round included undisclosed other investors…
